Johnson & Johnson

JNJ ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2016 FY2014 FY2013 FY2012 FY2011 FY2010 FY2008 FY2007
Operating Activities
Net Income $15.41B $16.32B $13.83B $10.85B $13.33B $12.27B $12.95B $10.58B
Depreciation & Amortization $3.75B $3.90B $4.10B $3.67B $2.94B $2.77B $2.83B $2.78B
Depreciation — — — — — — — —
Amortization $1.20B $1.40B $1.40B $1.15B $748.0M $0 $0 $678.0M
Stock-Based Compensation $874.0M $792.0M $728.0M $662.0M $614.0M $628.0M $627.0M $698.0M
Net Cash from Operating Activities $19.57B $18.71B $17.41B $15.40B $16.39B $16.57B $14.97B $15.02B
Investing Activities
Capital Expenditures $3.46B $3.71B $3.60B $2.93B $2.38B $2.37B $3.07B $2.94B
Business Acquisitions $954.0M $2.13B $835.0M $4.49B $1.27B $2.47B $1.21B $1.39B
Net Cash from Investing Activities $-7.74B $-12.31B $-5.10B $-4.51B $-7.85B $-7.60B $-4.19B $-5.91B
Financing Activities
Dividends Paid — — — — — — — —
Stock Repurchases $5.29B $7.12B $3.54B $12.92B $2.80B $2.13B $6.65B $5.61B
Net Cash from Financing Activities $-11.14B $-12.50B $-6.09B $-20.56B $-4.98B $-4.09B $-7.46B $-5.70B
Net Change in Cash $-791.0M $-6.40B $6.02B $-9.63B $3.55B $5.04B $3.00B $3.69B
Free Cash Flow $16.11B $15.00B $13.82B $12.46B $14.00B $14.21B $11.91B $12.08B
← Newer Page 2 of 2 Older →